ScreenerHero

APLIAppili Therapeutics Inc.

TSX · CA · Healthcare · Biotechnology · appilitherapeutics.com
0.0150CAD+50.00%Mkt Cap: 1.45M $P/E: —

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of treatments targeting unmet needs in infectious diseases in the United States and Canada. The company offers LIKMEZ (ATI…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap1.45M $
Enterprise Value10.84M $
Revenue (TTM)177.83K $
Gross Profit177.83K $
Net Income (TTM)-3.09M $
Revenue/Share0.0015 USD
Last Price0.0150 CAD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees7
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.25
PEG—
EV/EBITDA-2.28
EV/Revenue60.95
P/S5.42
P/B-0.08
EPS (TTM)-0.03
EPS (Forward)-0.04
52W Range
0.010017% of range0.0400
52W High0.0400 CAD
52W Low0.0100 CAD
Profitability
Gross Margin100.00%
Oper. Margin-11434.44%
EBITDA Margin0.00%
Profit Margin-1736.73%
ROE24.47%
ROA-214.89%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-973.98K $
CapEx (TTM)—
FCF Margin-1226.77%
FCF Yield-150.87%
Net Debt9.39M $
Net Debt/EBITDA-1.98
Balance Sheet
Debt/Equity-0.75
Current Ratio0.10
Quick Ratio0.10
Book Value/Sh-0.1310 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.132.37M
Float117.93M
Insiders0.06%
Institutions10.85%
Short Interest
Short Ratio0.6d
Short % Out.0.01%
Shares Short19.81K
Short (prev mo.)9.65K
Technical
SMA 500.0133 (+12.8%)
SMA 2000.0184 (-18.4%)
Beta-0.20
S&P 52W Chg18.16%
Avg Vol (30d)39.60K
Avg Vol (10d)82.05K
Technical Indicators
RSI (14)55.8
MACD-0.0008
MACD Signal-0.0011
MACD Hist.+0.0003
BB Upper0.0174 CAD
BB Middle0.0123 CAD
BB Lower0.0071 CAD
BB Width83.33%
ATR (14)0.0018 CAD
Vol Ratio (20d)0.07x